Zhen Bo Su

Direttore/Membro del Consiglio presso CASI PHARMACEUTICALS, INC.

48 anni

Consumer Services

Health Technology

Finance

Profilo

Mr. Zhen Bo Su is an Independent Director at CASI Pharmaceuticals, Inc., a Managing Partner at Shenzhen Share Investment LP and a Partner at Redhill Capital Investment Management Co. Ltd.
He is on the Board of Directors at CASI Pharmaceuticals, Inc. and Shenzhen Share Investment LP.
Mr. Su was previously employed as a Co-Founder by Chongqing TCR CURE Biopharma Technology Co., Ltd.
He received his undergraduate degree from Guangdong Medical University, a graduate degree from Sun Yat-Sen University and an MBA from The University of Chicago.

Posizioni attive di Zhen Bo Su

Società	Posizione	Inizio
CASI PHARMACEUTICALS, INC.	Direttore/Membro del Consiglio	21/03/2023
Shenzhen Share Investment LP Shenzhen Share Investment LP Investment ManagersFinance Shenzhen Share Investment LP is an independent venture capital firm founded in 2007 by Bai Wen Tao, Cui Xin Xin, and Huang Fan Zhi. The firm is headquartered in Shenzhen, China.	Direttore/Membro del Consiglio	-
Redhill Capital Investment Management Co. Ltd.	Corporate Officer/Principal	-

Tutte le posizioni attive di Zhen Bo Su

Precedenti posizioni note di Zhen Bo Su

Società	Posizione	Fine
Chongqing TCR CURE Biopharma Technology Co., Ltd Chongqing TCR CURE Biopharma Technology Co., Ltd Pharmaceuticals: MajorHealth Technology Chongqing TCR CURE Biopharma Technology Co., Ltd is a company that develops immunotherapy for T cell cancer. The company is based in Chongqing, China. and has subsidiaries in China. The Chinese company was founded in 2016 by Wei-Wu He, Zhen Bo Su, Qi-Jing Li, Pin Wang. Qi-Jing Li has been the CEO since 2016.	Fondatore	-

Vedi nel dettaglio l'esperienza di Zhen Bo Su

Formazione di Zhen Bo Su

Guangdong Medical University	Undergraduate Degree
Sun Yat-Sen University	Graduate Degree
The University of Chicago	Masters Business Admin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Zhen Bo Su

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
CASI PHARMACEUTICALS, INC.	Health Technology

Aziende private	3
Shenzhen Share Investment LP Shenzhen Share Investment LP Investment ManagersFinance Shenzhen Share Investment LP is an independent venture capital firm founded in 2007 by Bai Wen Tao, Cui Xin Xin, and Huang Fan Zhi. The firm is headquartered in Shenzhen, China.	Finance
Chongqing TCR CURE Biopharma Technology Co., Ltd Chongqing TCR CURE Biopharma Technology Co., Ltd Pharmaceuticals: MajorHealth Technology Chongqing TCR CURE Biopharma Technology Co., Ltd is a company that develops immunotherapy for T cell cancer. The company is based in Chongqing, China. and has subsidiaries in China. The Chinese company was founded in 2016 by Wei-Wu He, Zhen Bo Su, Qi-Jing Li, Pin Wang. Qi-Jing Li has been the CEO since 2016.	Health Technology
Redhill Capital Investment Management Co. Ltd.

Vedi le connessioni aziendali